Voltammetric quantitation of nitazoxanide by glassy carbon electrode

Rajeev Jain, Rajeev Kumar Yadav, Jahangir Ahmad Rather

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The present study reports voltammetric reduction of nitazoxanide in Britton-Robinson (B-R) buffer by cyclic and square-wave voltammetry at glassy carbon electrode. A versatile fully validated voltammetric method for quantitative determination of nitazoxanide in pharmaceutical formulation has been proposed. A squrewave peak current was linear over the nitazoxanide concentration in the range of 20-140 μg/mL. The limit of detection (LOD) and limit of quantification (LOQ) was calculated to be 5.23 μg/mL and 17.45 μg/mL, respectively.

Original languageEnglish
Pages (from-to)452-455
Number of pages4
JournalJournal of Pharmaceutical Analysis
Volume3
Issue number6
DOIs
Publication statusPublished - 2013

Fingerprint

nitazoxanide
Glassy carbon
Voltammetry
Drug products
Electrodes
Carbon
Drug Compounding
Limit of Detection
Buffers
Pharmaceutical Preparations

Keywords

  • Glassy carbon electrode
  • Nitazoxanide
  • Pharmaceutical formulation
  • Squarewave voltammetry

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Voltammetric quantitation of nitazoxanide by glassy carbon electrode. / Jain, Rajeev; Kumar Yadav, Rajeev; Ahmad Rather, Jahangir.

In: Journal of Pharmaceutical Analysis, Vol. 3, No. 6, 2013, p. 452-455.

Research output: Contribution to journalArticle

@article{378de57e01a24502ad3d1576adc19d68,
title = "Voltammetric quantitation of nitazoxanide by glassy carbon electrode",
abstract = "The present study reports voltammetric reduction of nitazoxanide in Britton-Robinson (B-R) buffer by cyclic and square-wave voltammetry at glassy carbon electrode. A versatile fully validated voltammetric method for quantitative determination of nitazoxanide in pharmaceutical formulation has been proposed. A squrewave peak current was linear over the nitazoxanide concentration in the range of 20-140 μg/mL. The limit of detection (LOD) and limit of quantification (LOQ) was calculated to be 5.23 μg/mL and 17.45 μg/mL, respectively.",
keywords = "Glassy carbon electrode, Nitazoxanide, Pharmaceutical formulation, Squarewave voltammetry",
author = "Rajeev Jain and {Kumar Yadav}, Rajeev and {Ahmad Rather}, Jahangir",
year = "2013",
doi = "10.1016/j.jpha.2013.07.005",
language = "English",
volume = "3",
pages = "452--455",
journal = "Journal of Pharmaceutical Analysis",
issn = "2095-1779",
publisher = "Xi'an Jiaotong University",
number = "6",

}

TY - JOUR

T1 - Voltammetric quantitation of nitazoxanide by glassy carbon electrode

AU - Jain, Rajeev

AU - Kumar Yadav, Rajeev

AU - Ahmad Rather, Jahangir

PY - 2013

Y1 - 2013

N2 - The present study reports voltammetric reduction of nitazoxanide in Britton-Robinson (B-R) buffer by cyclic and square-wave voltammetry at glassy carbon electrode. A versatile fully validated voltammetric method for quantitative determination of nitazoxanide in pharmaceutical formulation has been proposed. A squrewave peak current was linear over the nitazoxanide concentration in the range of 20-140 μg/mL. The limit of detection (LOD) and limit of quantification (LOQ) was calculated to be 5.23 μg/mL and 17.45 μg/mL, respectively.

AB - The present study reports voltammetric reduction of nitazoxanide in Britton-Robinson (B-R) buffer by cyclic and square-wave voltammetry at glassy carbon electrode. A versatile fully validated voltammetric method for quantitative determination of nitazoxanide in pharmaceutical formulation has been proposed. A squrewave peak current was linear over the nitazoxanide concentration in the range of 20-140 μg/mL. The limit of detection (LOD) and limit of quantification (LOQ) was calculated to be 5.23 μg/mL and 17.45 μg/mL, respectively.

KW - Glassy carbon electrode

KW - Nitazoxanide

KW - Pharmaceutical formulation

KW - Squarewave voltammetry

UR - http://www.scopus.com/inward/record.url?scp=84925835515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925835515&partnerID=8YFLogxK

U2 - 10.1016/j.jpha.2013.07.005

DO - 10.1016/j.jpha.2013.07.005

M3 - Article

VL - 3

SP - 452

EP - 455

JO - Journal of Pharmaceutical Analysis

JF - Journal of Pharmaceutical Analysis

SN - 2095-1779

IS - 6

ER -